A Study on the Assessment of Mental Cognitive Functions among the COPD Patients of Various Severity Stages
DOI:
https://doi.org/10.61427/jcpr.v2.i3.2022.64Keywords:
CAT, COPD, MMSEAbstract
Aim: The main aim of the study is to assess the mental cognitive functions among COPD patients of different severity stages. Materials and methods: This was a cross sectional study conducted for a period of 6 months in outpatient department of respiratory medicine. A total of 100 patients of both gender and of all age groups, who were diagnosed with COPD were included in the study. Results: Majority of the patients were observed with severe COPD (48%) followed by very severe COPD (26%). Majority of the patients were with moderate cognitive impairment (42%) followed by mild cognitive impairment (32%). Majority of the patients were observed to be with grade II (53%) followed by grade-I (23%). Most of the patients with very severe COPD were observed with moderate cognitive impairment (46.2%) followed by severe cognitive impairment (42.3%). Conclusion: In this study, majority of the patients with COPD were in the age group 45-54 years and most of the patients were observed with severe COPD. Majority of the patients were with moderate cognitive impairment and most of the patients were observed to be with grade II severity. Clinical pharmacists should take the responsibility in creating awareness regarding the cognitive functions among the COPD patients which may impact treatment strategies.
Downloads
References
Mannino DM, Buist AS. Global burden of COPD ; risk factors, prevelance, and future trends. Lancet 2007: 370(9589): 765-73.
Lee JM, Grab MC, Zipfel GJ, et al. Brain tissue response to ischemia. J Clin Invest, 2000:106: 723-31
Incalzi RA, Gemma A, Marra C, et al. Chronic Obstructive Pulmonary disease. An original model of cognitive decline. Am Rev Respir Dis, 1993: 148: 418-24.
Gupta N, Pinto LM, Morogan A, Bourbeau J. The COPD assessment test: a systematic review. Eur Respir J. 2014 Oct;44(4):873-84.
Korsnes MS. Performance on the mini-mental state exam and the Montreal cognitive assessment in a sample of old age psychiatric patients. SAGE Open Med. 2020 Sep 11;8:2050312120957895.
Giulia Prinzi, Alessia Santoro, Palma Lamanaca et al. Cognitive Impairment in COPD, Journal of Marine Drugs, 2018: 16(9): 313.
Richards JB. Calculated decisions: mMRC (Modified Medical Research Council) Dyspnea Scale. Emerg Med Pract. 2017 Oct 25 ;19 (Suppl 10):1-2.
Chelsea BJ, Lovell M et al. Impact of cognitive impairment on self management in COPD. Journal of Respiratory Medicine , 2017: (129): 130-9.
Maria Paz Moreno-Ramirez and Marie Carmen Valenza et al, Relationship between various cognitive domains affected in COPD patients, International Journal of Chronic Obstructive Pulmonary Disease, 2014:1289.
Minna J Hynnenen, Nina Bjerke, State Pallesen et al. Randomized Controlled trail of cognitive behavioral therapy for anxiety and depression in COPD, Journal of Respiratory Medicine, 2010:104(7): 986-94.
Reddipalli Manasa, Mattaparthi Monika, Bhukya Naga Vamsi Naik, Oselebe Somto Dave, Himasree Pithani, Magharla Dasaratha Dhanaraju. A Study on the Drug Utilization Pattern of Oral and Inhaled Corticosteroids among the COPD Patients. J Cli Pharm Res. 2021; 1(4):65-8.
Published
How to Cite
Issue
Section
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Most read articles by the same author(s)
- Kranthi Priya P, Nisha Singh, Gunawanti Babu Ch, Ramya M, Amit Kumar, A Review on the Prevalence of Cervical Dysplasia in Various Geographical Locations , Journal of Clinical and Pharmaceutical Research: JCPR Volume:2/Issue:4 (2022)
.